Coagulopathy
72
5
5
37
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
4 terminated out of 72 trials
90.2%
+3.7% vs benchmark
13%
9 trials in Phase 3/4
19%
7 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 37 completed trials
Clinical Trials (72)
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
Fibrinogen Early In Severe Trauma StudY II
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
Assessment of Artificial Intelligence Algorithms for ROTEM
Association Between Hypomagnesemia and Coagulopathy in Sepsis
Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients
ROTEM Interpretation AI vs Experts
Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study
Microcirculation and Coagulopathy in Sepsis
Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage
Ascending Dose Study of FrontlineODP™ Spray Dried Plasma
Predictive Accuracy of PLR and PNR in Detecting ETIC
Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen
Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Transfusion Using Stored Whole Blood
Patient Blood Management Implementation in CEE Study
Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological Coagulopathy
Thrombelastography for Coagulopathy in Chinese Snakebites